Cyclopharm Ltd (CYC.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -804 | -237 | -1,274 | -843 | -194 |
| Net Acquisitions | N/A | -32 | N/A | N/A | -343 |
| Purchase Sale Intangibles | -168 | -301 | -274 | -318 | -337 |
| Other Investing Activity | 0 | 32 | 0 | 0 | 0 |
| Investing Cash Flow | $-972 | $-538 | $-1,548 | $-1,161 | $-874 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 24,003 | N/A | N/A | 33,000 | N/A |
| Common Stock Repurchased | -1,145 | N/A | N/A | -1,658 | N/A |
| Dividend Paid | N/A | -885 | -883 | -881 | -752 |
| Other Financing Activity | -636 | -134 | 157 | -289 | -234 |
| Financing Cash Flow | $22,222 | $-1,019 | $-726 | $30,172 | $-986 |
| Exchange Rate Effect | 166 | 155 | -15 | -7 | 9 |
| Beginning Cash Position | 11,726 | 20,296 | 29,249 | 1,874 | 12,660 |
| End Cash Position | 20,568 | 11,726 | 20,296 | 29,249 | 1,874 |
| Net Cash Flow | $8,676 | $-8,725 | $-8,939 | $27,382 | $-10,795 |
| Free Cash Flow | |||||
| Capital Expenditure | -972 | -538 | -1,548 | -1,161 | -531 |
| Free Cash Flow | -972 | -538 | -1,548 | -1,161 | -531 |